Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
To be added to the distribution list email: DDeCastro@southlakeregional.org
This episode will review the practical clinical management of Biliary Tract cancer in 2022. We will focus on recent evidence-based additions to standard of care treatments, as well as recent advances in genomic profiling and NGS driven treatment strategies.
Key Opinion Leader: Dr. Jennifer Knox Professor of Medicine Clinician Investigator, Medical Oncologist Princess Margaret Cancer Centre University of Toronto
Host: Dr. Shaqil Kassam skassam@southlakeregional.org Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
POD Cast Legend: Introduction: 0:00 BTC diagnostic work up: 2:10 Treatment -ICCA vs. ECCA vs GB: 5:00 1st Line therapy - Targeted therapy vs. Chemo/IO: 6:40 1st Line therapy BTC: 8:10 2nd Line therapy BTC: 20:00 NGS and BTC: 22:38 FGFR2 fusion/rearrangements: 23:50
Previous Episodes: Gastric Cancer: http://tobtr.com/12051154 NGS: http://tobtr.com/12072620 Paxlovid and Cancer treatment:http://tobtr.com/12090165